Kodiak Sciences (KOD) Competitors $8.65 -0.03 (-0.35%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends KOD vs. GLPG, XNCR, EVO, ARQT, NRIX, KNSA, RCUS, IMCR, OCUL, and TVTXShould you be buying Kodiak Sciences stock or one of its competitors? The main competitors of Kodiak Sciences include Galapagos (GLPG), Xencor (XNCR), Evotec (EVO), Arcutis Biotherapeutics (ARQT), Nurix Therapeutics (NRIX), Kiniksa Pharmaceuticals (KNSA), Arcus Biosciences (RCUS), Immunocore (IMCR), Ocular Therapeutix (OCUL), and Travere Therapeutics (TVTX). These companies are all part of the "pharmaceutical products" industry. Kodiak Sciences vs. Galapagos Xencor Evotec Arcutis Biotherapeutics Nurix Therapeutics Kiniksa Pharmaceuticals Arcus Biosciences Immunocore Ocular Therapeutix Travere Therapeutics Kodiak Sciences (NASDAQ:KOD) and Galapagos (NASDAQ:GLPG) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, earnings, valuation, profitability, dividends, media sentiment and institutional ownership. Which has better earnings and valuation, KOD or GLPG? Galapagos has higher revenue and earnings than Kodiak Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKodiak SciencesN/AN/A-$260.49M-$3.65-2.37Galapagos$260.09M6.78$229.12MN/AN/A Do analysts recommend KOD or GLPG? Kodiak Sciences presently has a consensus price target of $8.00, indicating a potential downside of 7.51%. Galapagos has a consensus price target of $30.75, indicating a potential upside of 14.91%. Given Galapagos' higher possible upside, analysts plainly believe Galapagos is more favorable than Kodiak Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kodiak Sciences 1 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00Galapagos 2 Sell rating(s) 5 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.71 Do insiders & institutionals believe in KOD or GLPG? 89.1% of Kodiak Sciences shares are owned by institutional investors. Comparatively, 32.5% of Galapagos shares are owned by institutional investors. 45.3% of Kodiak Sciences shares are owned by insiders. Comparatively, 2.9% of Galapagos shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community believe in KOD or GLPG? Galapagos received 447 more outperform votes than Kodiak Sciences when rated by MarketBeat users. Likewise, 64.10% of users gave Galapagos an outperform vote while only 27.54% of users gave Kodiak Sciences an outperform vote. CompanyUnderperformOutperformKodiak SciencesOutperform Votes1927.54% Underperform Votes5072.46% GalapagosOutperform Votes46664.10% Underperform Votes26135.90% Is KOD or GLPG more profitable? Galapagos' return on equity of 0.00% beat Kodiak Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Kodiak SciencesN/A -84.52% -45.40% Galapagos N/A N/A N/A Does the media prefer KOD or GLPG? In the previous week, Galapagos had 2 more articles in the media than Kodiak Sciences. MarketBeat recorded 2 mentions for Galapagos and 0 mentions for Kodiak Sciences. Galapagos' average media sentiment score of 0.68 beat Kodiak Sciences' score of 0.00 indicating that Galapagos is being referred to more favorably in the news media. Company Overall Sentiment Kodiak Sciences Neutral Galapagos Positive Which has more volatility & risk, KOD or GLPG? Kodiak Sciences has a beta of 2.38, suggesting that its stock price is 138% more volatile than the S&P 500. Comparatively, Galapagos has a beta of 0.23, suggesting that its stock price is 77% less volatile than the S&P 500. SummaryGalapagos beats Kodiak Sciences on 9 of the 14 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Kodiak Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for KOD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart KOD vs. The Competition Export to ExcelMetricKodiak SciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$455.20M$2.94B$5.10B$9.07BDividend YieldN/A1.90%4.90%4.21%P/E Ratio-2.3745.9491.0817.15Price / SalesN/A411.851,113.51116.81Price / CashN/A182.1042.2637.86Price / Book1.713.894.784.78Net Income-$260.49M-$42.21M$119.77M$225.60M7 Day Performance2.13%-2.14%-1.87%-1.23%1 Month Performance46.61%4.21%11.46%3.07%1 Year Performance194.22%18.39%30.53%16.48% Kodiak Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)KODKodiak Sciences2.2957 of 5 stars$8.65-0.3%$8.00-7.5%+210.0%$455.20MN/A-2.3790Gap DownGLPGGalapagos0.6163 of 5 stars$27.03+0.8%$30.75+13.8%-31.4%$1.78B$260.09M0.001,123XNCRXencor4.3204 of 5 stars$25.18+4.8%$36.56+45.2%+18.4%$1.76B$168.34M-7.51280EVOEvotec2.387 of 5 stars$4.69+4.5%$5.93+26.5%-60.5%$1.66B$777.05M0.005,061Positive NewsARQTArcutis Biotherapeutics0.8599 of 5 stars$13.36+5.3%$15.50+16.0%+478.8%$1.56B$138.71M-7.58150Options VolumePositive NewsNRIXNurix Therapeutics2.5066 of 5 stars$21.18+4.5%$30.35+43.3%+101.7%$1.50B$56.42M-6.97300News CoverageKNSAKiniksa Pharmaceuticals2.5299 of 5 stars$20.60+2.0%$36.60+77.7%+15.4%$1.49B$384.10M-147.36220Positive NewsRCUSArcus Biosciences2.6476 of 5 stars$16.24+1.0%$34.00+109.4%-9.3%$1.49B$117M-5.11500News CoverageIMCRImmunocore2.4974 of 5 stars$29.51+2.1%$65.64+122.4%-51.4%$1.48B$296.31M-30.43497Short Interest ↓OCULOcular Therapeutix3.6461 of 5 stars$9.06+4.3%$16.71+84.5%+116.8%$1.42B$58.44M0.00267Positive NewsTVTXTravere Therapeutics2.7678 of 5 stars$17.84+3.0%$22.62+26.8%+106.0%$1.39B$145.24M-3.81460Positive News Related Companies and Tools Related Companies GLPG Competitors XNCR Competitors EVO Competitors ARQT Competitors NRIX Competitors KNSA Competitors RCUS Competitors IMCR Competitors OCUL Competitors TVTX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:KOD) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kodiak Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kodiak Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KOD Stock Alerts